|
This session will feature six
30-minute Invited Lectures from diverse regions of the world:
the Middle East, the Far East, Africa, Europe, North America
and South America. Each speaker is to cover the status of
biomedical research in their respective regions, especially
as it relates to the discovery of new therapeutics and diagnostics
for the public good. The very nature of pharmaceutical research
has changed dramatically over the past decade, with globalization
and networked interactions becoming more prevalent. In addition,
there is an increased emphasis being placed upon diseases
and disorders of the third world such as for the neglected
diseases that afflict one-sixth of humanity. This track of
the 2nd ICDDT is a novel experiment to promote a more globally
integrated review of pharmaceutical research.
Allen B. Reitz
Institute of Hepatitis and Virus Research
PA, USA
|
|
| | Dr. Reitz has had 27 years of experience as a medicinal chemist in the pharmaceutical industry, including nearly 26 years with Johnson & Johnson. He is a co-inventor as well as Team Leader in most cases of seven compounds that have entered human clinical trials, several of which are currently in the clinic (Phase I and II). He has ca. 130 scientific publications and 40 issued U.S. patents, and is the Editor-in-Chief of the journal Current Topics in Medicinal Chemistry. He has extensive experience in probe design and synthesis, target validation, hit triage, hit to lead and lead optimization medicinal chemistry, eADME profiling, and preclinical candidate selection. Dr. Reitz is located at the Pennsylvania Biotechnology Center in Doylestown, PA with research interests in the area of anti-infective agents, protein function and neurology (amyotrophic lateral sclerosis). Dr. Reitz is also Prof. of Chemical Biology in the Institute of Hepatitis and Virus Research.
|
| Scientific and Professional
Activities: Include being a Medicinal Chemistry consultant
for the Special Programme for Training and Research in the
Tropical Diseases (TDR/WHO), American Chemistry Society, and
the Philadelphia Organic Chemists Club.
|
|
|
